OCAR
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Oct 2025)
What this means for you
This application is over — abandoned 08 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90624467
- Mark type
- Stylized text
- Filed
- 05 Apr 2021
- Published for opposition
- 07 Dec 2021
- Abandoned
- 08 Oct 2025
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Therapeutic pharmaceutical for the treatment of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders
Owner
- ORNA THERAPEUTICS, INC., Watertown, MA, US
- ORNA THERAPEUTICS, INC., Cambridge, MA, US
Prosecution history
- 08 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2024 — SOU EXTENSION 5 GRANTED
- 17 Jul 2024 — SOU EXTENSION 5 FILED
- 17 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 20 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jan 2024 — SOU EXTENSION 4 GRANTED
- 18 Jan 2024 — SOU EXTENSION 4 FILED
- 18 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Nov 2023 — ASSIGNED TO EXAMINER
- 28 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2023 — SOU EXTENSION 3 GRANTED
- 26 Jul 2023 — SOU EXTENSION 3 FILED
- 26 Jul 2023 — SOU TEAS EXTENSION RECEIVED